$WAY

Hawkins Matthew J. sold $2.2M of WAY

Hawkins Matthew J. (Chief Executive Officer) sold 82,500 shares of Waystar Holding Corp. (WAY) at $26.23 ($2.16M total) on 2026-10-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Hawkins Matthew J.
Published Oct 7, 2026, 8:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$WAY
Neutral
medium confidence
Mentioned
$WAY
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WAYNeutralLow
01

Why it matters

The disclosed sale reduces the CEO's ownership but leaves him with a substantial stake, suggesting continued confidence.

02

Market read

A modest insider sale that may cause slight short‑term price pressure.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 5/10Novelty 4/10Timing: after‑hours on 2026‑10‑06

Background

Form 4 filings provide the first public disclosure of insider transactions.

Company-level read

Ticker impact

$WAYNeutralMedium confidence
Context

CEO Hawkins sold 82,500 shares for $2.16M via a 10b5‑1 plan, reducing his stake to 1.8M shares.

Expected impact

likely slight downward pressure as the market prices the sale

Evidence & confidence

A $2M sale by the CEO is material enough to be noted but is not large enough to drive a significant move.

Market effects

Minimal impact on the healthcare services sector; no broader industry signal.

Limited to U.S. investors tracking Waystar.

None

Counterpoint

The sale could be a routine liquidity event unrelated to company outlook.

Key entities

  • Waystar Holding Corp.

    Provider of revenue cycle management and technology solutions.

  • Hawkins Matthew J.

    Chief Executive Officer of Waystar.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WAYHigh

WAY Stock Surges On Reported Sale Buzz — RBC Flags This Tech Giant As The ‘Obvious First Name’

Waystar (WAY) shares rose 8% after Reuters reported the company is exploring a sale, with RBC naming Oracle (ORCL) as a potential buyer. Waystar hired Evercore to explore options, though no deal is guaranteed. RBC maintains an 'Outperform' rating with a $44 target, citing strong private-market valuations. Evercore also sees a sale as plausible given WAY's 24% decline this year.

$WAYMed

Exclusive-Healthcare software firm Waystar explores options including sale, sources say

Waystar, a healthcare software firm, is exploring strategic options, including a potential sale, according to seven sources. The company, which went public in 2024, has hired Evercore as an advisor. Waystar's market value has dropped to $4.8 billion after a 24% decline in its share price this year. The company's strategy aims to leverage higher tech valuations, but investor concerns about AI disruption have pressured its stock.

$WAYHigh

Why is Waystar stock surging today?

Waystar stock surged 9.2% in pre-market trading after reports it is exploring strategic options, including a potential sale. Key institutional shareholders, such as EQT and BlackRock, hold significant stakes. The stock is below its 52-week high of $40.35, offering potential upside for acquirers. The rally is driven by company-specific news, not broader market trends.